Cornell University College of Engineering

Conceptual illustration of C’ dot nanoparticles adapted with HER2-targeting antibody fragments (dark blue and green) and cancer-killing drugs (teal), entering a tumor cell via HER2 receptors (orange).
Completely eradicating gastric cancer with an antibody fragment-nanoparticle therapeutic: in mice